Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shimoni

Showing results (581-590 of 778) with videos related to

Pageof 78
Sort By:
Mabs|September 29, 2012
Identification of a single base-pair mutation of TAA (Stop codon) → GAA (Glu) that causes light chain extension in a CHO cell derived IgG1Taylor Zhang, Yungfu Huang, Scott Chamberlain, et al.
Cell Reports|March 12, 2020
ERM-Dependent Assembly of T Cell Receptor Signaling and Co-stimulatory Molecules on Microvilli prior to ActivationShirsendu Ghosh, Vincenzo Di Bartolo, Liron Tubul, et al.
European Journal of Haematology|November 13, 2013
OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patientsMaya Koren-Michowitz, Zehavit Buzaglo, Elena Ribakovsky, et al.
Harefuah|July 24, 2025
[DIAGNOSING AUTISM SPECTRUM DISORDER (ASD) IN MEDICAL SETTINGS: THE PEER GROUP OBSERVATION TECHNIQUE- THREE CASE STUDIES]Hagit Nagar Shimoni, Shahar Gindi, Efrat Zilbershot Fink, et al.
Bone Marrow Transplantation|August 30, 2019
Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosisRoni Shouval, Yakov Vega, Joshua A Fein, et al.
Immunology Letters|December 1, 1993
Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicityR N Apte, A Douvdevani, M Zoller, et al.
Folia Biologica|January 1, 1994
Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implicationsR N Apte, A Douvdevani, M Zoller, et al.
ACS Omega|May 30, 2023
Interaction of Pexiganan (MSI-78)-Derived Analogues Reduces Inflammation and TLR4-Mediated Cytokine Secretion: A Comparative StudyHadar Cohen, Naiem Ahmad Wani, Daniel Ben Hur, et al.
Journal of Clinical Medicine|December 24, 2021
Percutaneous Mitral Valve Repair in Patients with Severe Mitral Regurgitation and Acute Decompensated Heart FailureAnna Turyan Medvedovsky, Dan Haberman, Mahsati Ibrahimli, et al.
Journal of Hematology & Oncology|October 10, 2022
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progressionKatia Beider, Valeria Voevoda-Dimenshtein, Ali Zoabi, et al.
Pageof 78

Showing results (581-590 of 778) with videos related to

Sort By:
Pageof 78
Mabs|September 29, 2012
Identification of a single base-pair mutation of TAA (Stop codon) → GAA (Glu) that causes light chain extension in a CHO cell derived IgG1Taylor Zhang, Yungfu Huang, Scott Chamberlain, et al.
Cell Reports|March 12, 2020
ERM-Dependent Assembly of T Cell Receptor Signaling and Co-stimulatory Molecules on Microvilli prior to ActivationShirsendu Ghosh, Vincenzo Di Bartolo, Liron Tubul, et al.
European Journal of Haematology|November 13, 2013
OCT1 genetic variants are associated with long term outcomes in imatinib treated chronic myeloid leukemia patientsMaya Koren-Michowitz, Zehavit Buzaglo, Elena Ribakovsky, et al.
Harefuah|July 24, 2025
[DIAGNOSING AUTISM SPECTRUM DISORDER (ASD) IN MEDICAL SETTINGS: THE PEER GROUP OBSERVATION TECHNIQUE- THREE CASE STUDIES]Hagit Nagar Shimoni, Shahar Gindi, Efrat Zilbershot Fink, et al.
Bone Marrow Transplantation|August 30, 2019
Allogeneic hematopoietic stem cell transplantation with fludarabine, busulfan, and thiotepa conditioning is associated with favorable outcomes in myelofibrosisRoni Shouval, Yakov Vega, Joshua A Fein, et al.
Immunology Letters|December 1, 1993
Cytokine-induced tumor immunogenicity: endogenous interleukin-1 alpha expressed by fibrosarcoma cells confers reduced tumorigenicityR N Apte, A Douvdevani, M Zoller, et al.
Folia Biologica|January 1, 1994
Involvement of immune responses in the eradication of IL-1 alpha gene-transduced tumour cells: mechanisms of tumour rejection and immunotherapeutical implicationsR N Apte, A Douvdevani, M Zoller, et al.
ACS Omega|May 30, 2023
Interaction of Pexiganan (MSI-78)-Derived Analogues Reduces Inflammation and TLR4-Mediated Cytokine Secretion: A Comparative StudyHadar Cohen, Naiem Ahmad Wani, Daniel Ben Hur, et al.
Journal of Clinical Medicine|December 24, 2021
Percutaneous Mitral Valve Repair in Patients with Severe Mitral Regurgitation and Acute Decompensated Heart FailureAnna Turyan Medvedovsky, Dan Haberman, Mahsati Ibrahimli, et al.
Journal of Hematology & Oncology|October 10, 2022
CXCL13 chemokine is a novel player in multiple myeloma osteolytic microenvironment, M2 macrophage polarization, and tumor progressionKatia Beider, Valeria Voevoda-Dimenshtein, Ali Zoabi, et al.
Pageof 78